Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation

被引：23
|
作者：
Cutting, Rob [1 ]
Mirelman, Anna [1 ]
Vora, Ajay [1 ]
机构：
[1] Sheffield Childrens Hosp, Dept Paediat Haematol, Sheffield S10 2TH, S Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 143卷 / 05期
关键词：
child; allogeneic transplant; treosulphan; conditioning;
D O I：
10.1111/j.1365-2141.2008.07399.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：748 / 751
页数：4
相关论文
共 50 条
  • [31] A comparison of non-myeloablative versus reduced conditioning for allogeneic stem cell transplantation
    Ringdén, O
    Le Blanc, K
    Uzunel, M
    Mattsson, J
    Barkholt, L
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S38 - S38
  • [32] Outcomes of allogeneic transplantation with non-myeloablative conditioning in patients with myelodysplastic and overlap syndromes
    Hilali, Ammar
    Hibbs, Stephen
    Davies, Jeff
    Smith, Matthew
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 227 - 228
  • [33] MYELOABLATIVE CONDITIONING PREDISPOSES FOR TOXOPLASMA GONDII REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Meers, S.
    Lagrou, K.
    Delforge, M.
    Devos, T.
    Dierickx, D.
    Janssens, A.
    Verhoef, G.
    Maertens, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 444 - 444
  • [34] Allogeneic stem cell transplantation with non-myeloablative conditioning for Hypereosinophilic Syndrome (HES)
    Juvonen, E
    Volin, L
    Elonen, E
    Koponen, A
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2001, 27 : S288 - S288
  • [35] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [36] MYELOABLATIVE CONDITIONING WITH INTRAVENOUS BUSULPHAN IN A SINGLE DAILY DOSE AND FLUDARABINE (BUF) FOR HLA-IDENTICAL SIBLING ALLOGENEIC HSCT IN MYELOID MALIGNANCIES
    De la Serna, J.
    Bermudez, A.
    Sanz, J.
    Caballero, D.
    De la Camara, R.
    Vallejo, C.
    Serrano, D.
    Moraleda, J. M.
    Benlloch, L.
    Sanz, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S299 - S299
  • [37] Unrelated cord blood transplantation with non-myeloablative conditioning regimen in paediatric acute leukaemia
    Ahn, HS
    Kang, HJ
    Park, ES
    Choi, HS
    Shin, HY
    BONE MARROW TRANSPLANTATION, 2005, 35 : S365 - S365
  • [38] Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome
    E Juvonen
    L Volin
    A Koponen
    T Ruutu
    Bone Marrow Transplantation, 2002, 29 : 457 - 458
  • [39] FLUDARABINE AND TREOSULFAN CONDITIONING FOR ALLOGENEIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH AML AND MDS NOT ELIGIBLE FOR STANDARD MYELOABLATIVE CONDITIONING
    Shimoni, A.
    Crotta, A.
    Shem-Tov, N.
    Peccatori, J.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    HAEMATOLOGICA, 2012, 97 : 177 - 177
  • [40] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
12345